aTyr Pharma to Participate in Upcoming Investor Conferences
Globe Newswire•11/11/2026•08:00 ET
0
Key Highlights
- ➤aTyr to participate in Jefferies Global Healthcare Conference November 17-18
- ➤aTyr CEO Sanjay S. Shukla to lead Piper Sandler fireside chat December 3
- ➤Piper Sandler webcast and replay will be available on aTyr’s website
Expert Statements
Sanjay S. Shukla, President and Chief Executive Officer of aTyr Pharma
“Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer”
SAN DIEGO, Nov. 11, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the company will participate in two upcoming investor conferences scheduled to take place in November and December 2026.
Conference: 2026 Jefferies Global Healthcare Conference in London Date: Tuesday, November 17 and Wednesday, November 18, 2026 Location: London, UK Format: 1x1 Investor Meetings
Get started
Create a free account to read the full story.